Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,944 | -11,423 | -61,850 | -47,312 | -31,905 |
| Depreciation Amortization | 4,012 | 1,988 | 6,410 | 4,706 | 2,977 |
| Accounts receivable | 3,501 | 2,566 | -1,555 | 1,272 | 1,795 |
| Accounts payable and accrued liabilities | -1,853 | -1,361 | 2,557 | -1,468 | -3,134 |
| Other Working Capital | 866 | 126 | -11,265 | -7,157 | -5,315 |
| Other Operating Activity | 4,981 | 2,052 | 12,281 | 9,354 | 7,415 |
| Operating Cash Flow | $-16,437 | $-6,052 | $-53,422 | $-40,605 | $-28,167 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 18,978 | 10,100 | -19,593 | -34,129 | 17,996 |
| PPE Investments | -924 | -465 | -4,815 | -3,816 | -2,535 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -10,496 |
| Purchase Sale Intangibles | N/A | N/A | -500 | -500 | N/A |
| Other Investing Activity | 0 | 0 | -500 | -500 | 0 |
| Investing Cash Flow | $18,054 | $9,635 | $-24,908 | $-38,445 | $4,965 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 0 | 15,000 | 15,000 | 15,000 |
| Debt Repayment | -45 | -22 | -7,848 | -6,123 | -964 |
| Common Stock Issued | 557 | 17 | 87,554 | 87,048 | 87,005 |
| Other Financing Activity | -20 | -20 | -5,656 | -5,656 | -5,358 |
| Financing Cash Flow | $492 | $-25 | $89,050 | $90,269 | $95,683 |
| Exchange Rate Effect | 28 | -34 | 75 | -17 | -13 |
| Beginning Cash Position | 27,512 | 27,512 | 16,717 | 16,717 | 16,717 |
| End Cash Position | 29,649 | 31,036 | 27,512 | 27,919 | 89,185 |
| Net Cash Flow | $2,137 | $3,524 | $10,795 | $11,202 | $72,468 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,437 | -6,052 | -53,422 | -40,605 | -28,167 |
| Capital Expenditure | -924 | -465 | -4,815 | -3,816 | -2,535 |
| Free Cash Flow | -17,361 | -6,517 | -58,237 | -44,421 | -30,702 |